You are here » Home » Companies » Company Overview » Ankur Drugs & Pharma Ltd

Ankur Drugs & Pharma Ltd.

BSE: 531683 Sector: Health care
NSE: ANKURDRUGS ISIN Code: INE238D01012
BSE 05:30 | 01 Jan Ankur Drugs & Pharma Ltd
NSE 05:30 | 01 Jan Ankur Drugs & Pharma Ltd
Filter:

Ankur Drugs & Pharma Ltd. (ANKURDRUGS) - Nine Monthly Result

Particulars ( cr) Dec '12 Dec '11 Dec '10 Dec '09 Dec '08
Net Sales/Income From Operations 104.90 115.14 703.21 806.11 722.26
Other Income 0.04 0.05 0.93 16.34 1.53
Total Income 104.94 115.19 704.14 822.45 723.79
Total Expenditure 110.13 135.42 569.63 648.70 604.82
Operating Profit -5.19 -20.23 134.51 173.75 118.97
Interest 73.01 36.00 76.04 57.45 36.84
Gross Profit -78.20 -56.23 58.47 116.30 82.13
Depreciation 49.60 45.80 38.95 17.76 15.86
PBT -127.80 -102.03 19.52 94.54 61.66
Tax 0.00 0.00 3.90 16.76 9.38
Net Profit/(Loss) -127.80 -102.03 15.62 77.78 52.28
Minority Interest After NP - - - - -
Net Profit after Minority Interest - - - - -
Exceptional Items 0.00 0.00 0.61 1.06 0.00
Profit After Exceptional Items -127.80 -102.03 15.01 76.72 52.28
Equity Share Capital 19.34 19.34 19.34 19.34 18.62
Reserves Excluding Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
EPS
Basic EPS -66.08 -52.75 8.08 40.21 28.08
Public Share Holding
No Of Shares (Crores) 1.82 1.59 1.49 1.22 1.2
Share Holding (%) 94.10 82.38 76.95 63.21 64.25
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of Shares (Crores) 0.01 0.24 0.35 0.3 0
- Per. of Shares (as a % of the total sh. of prom. and promoter group) 12.36 71.65 77.92 41.75 0.00
- Per. of Shares (as a % of the total Share Cap. of the company) 0.73 12.62 17.96 15.37 0.00
b) Non-encumbered
- Number of Shares (Crores) 0.1 0.1 0.1 0.41 0
- Per. of shares (as a % of the total sh. of prom. and promoter group) 87.64 28.35 22.08 58.25 0.00
- Per. of shares (as a % of the total Share Cap. of the company) 5.17 4.99 5.09 21.45 0.00
Note : PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure.